Abstract: Background: Stroke is a serious disease that entails an enormous burden of mortality, morbidity, disability and health care cost in the United States. Ischemic stroke accounts for 80 percent of all stroke cases. The aim of this study was to assess the emergency nurse's knowledge and practice regarding care of acute ischemic stroke patients undergoing recombinant tissue plasminogen activator. Data collection tools: the current study was collected by utilized three tools: tool one: socio demographic data, tool two: nurses' knowledge assessment questionnaire and tool three: observational checklist assessment sheet. Results: The mean age of the studied nurses was 25.3 ± 8.3 years. More than half of studied nurses had unsatisfactory level of total knowledge regarding care of acute ischemic stroke patients. The most of the studied nurses had competent regarding care of acute ischemic stroke patients.....
Keywords: Acute Ischemic Stroke, Nurses' Knowledge and Practice, Recombinant Tissue Plasminogen Activator
[1]. Abd Allah F. Khedr E. Oraby M., Bedair A., Georgy Sh., and Moustafa R. (2018). Stroke burden in egypt: data from five epidemiological studies. International journal of neuroscience ; 128(8). Pubmed.
[2]. Baatiema, L., Aikins, A. d.-G., Sav, A., Mnatzaganian, G., Chan, C. K., & Somerset, S. (2017). Barriers to evidence-based acute stroke care in Ghana: a qualitative study on the perspectives of stroke care professionals. BMJ open, 7(4), e015385.
[3]. Berrouschot, J., Stoll, A., Hogh, T., & Eschenfelder, C. C. (2016). Intravenous thrombolysis with recombinant tissue-type plasminogen activator in a stroke patient receiving dabigatran anticoagulant after antagonization with idarucizumab. Stroke, 47(7), 1936-1938.
[4]. Bledsoe, B. E., Casey, M. J., Feldman, J., Johnson, L., Diel, S., Forred, W., & Gorman, C. (2015). Glasgow Coma Scale scoring is often inaccurate. Prehospital and disaster medicine, 30(1), 46-53.
[5]. Chapman, S. N., Mehndiratta, P., Johansen, M. C., McMurry, T. L., Johnston, K. C., & Southerland, A. M. (2014). Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vascular health and risk management, 10, 75.